Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames-Reference-Cited by-同舟云学术

Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames

Published:2016-01-05 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Laumont Céline M.,Daouda Tariq,Laverdure Jean-Philippe,Bonneil Éric,Caron-Lizotte Olivier,Hardy Marie-Pierre,Granados Diana P.,Durette Chantal,Lemieux Sébastien,Thibault Pierre,Perreault Claude^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms10238.pdf

Reference70 articles.

1. Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101–108 (2012).

2. Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575–581 (2014).

3. Weekes, M. P. et al. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157, 1460–1472 (2014).

4. Alfaro, J. A., Sinha, A., Kislinger, T. & Boutros, P. C. Onco-proteogenomics: cancer proteomics joins forces with genomics. Nat. Methods 11, 1107–1113 (2014).

5. Nesvizhskii, A. I. Proteogenomics: concepts, applications and computational strategies. Nat. Methods 11, 1114–1125 (2014).

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation;Computational and Structural Biotechnology Journal;2024-12

2. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy;International Immunopharmacology;2024-12

3. Noncanonical microprotein regulation of immunity;Molecular Therapy;2024-09

4. Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort;Science Advances;2024-07-12

5. Components, Formulations, Deliveries, and Combinations of Tumor Vaccines;ACS Nano;2024-07-09